A phase II study of decitabine and gemtuzumab ozogamicin in newly diagnosed and relapsed acute myeloid leukemia and high-risk myelodysplastic syndrome. (Q36682845)
Jump to navigation
Jump to search
scientific article published on 14 September 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase II study of decitabine and gemtuzumab ozogamicin in newly diagnosed and relapsed acute myeloid leukemia and high-risk myelodysplastic syndrome. |
scientific article published on 14 September 2015 |
Statements
A phase II study of decitabine and gemtuzumab ozogamicin in newly diagnosed and relapsed acute myeloid leukemia and high-risk myelodysplastic syndrome (English)
N Daver
H Kantarjian
F Ravandi
E Estey
X Wang
G Garcia-Manero
E Jabbour
M Konopleva
S O'Brien
T Kadia
C Dinardo
S Pierce
X Huang
N Pemmaraju
M Diaz-Pines-Mateo
J Cortes
14 September 2015
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference